Tissue Microarray Immunohistochemical Expression Analysis of Mismatch Repair (hMLH1 and hMSH2 Genes) in Endometrial Carcinoma and Atypical Endometrial Hyperplasia: Relationship with Microsatellite Instability

Modern Pathology

Volumn 16, Issue 11, 2003, Pages 1148-1158

  Hardisson, David ^a   Moreno Bueno, Gema ^b   Sánchez, Lydia ^b   Sarrió, David ^b   Suárez, Asunción ^a   Calero, Francisco ^a   Palacios, José ^b  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Atypical endometrial hyperplasia; Endometrial carcinoma; hMLH1; hMSH2; Immunohistochemistry; Microsatellite instability; Mismatch repair proteins; Tissue microarray

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; GENE; GENE EXPRESSION; GENETIC SCREENING; HMLH1 GENE; HMSH2 GENE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MARKER GENE; MICROSATELLITE INSTABILITY; MISMATCH REPAIR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; CARRIER PROTEINS; DNA-BINDING PROTEINS; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSATELLITE REPEATS; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS;

EID: 0242439284     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000095646.70007.6A     Document Type: Article

References (50)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-29.
2. Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, et al. Molecular pathology of endometrial carcinoma and hyperplasia. Hum Pathol 2001;32:569-77.
3. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulus N, Jen J, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
4. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
5. Risinger JI, Berchuck A, Kohler MF, Watson P, Lynch HT, Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res 1993;53:5100-3.
6. Duggan BD, Felix JC, Mudersprach LI, Turgeman D, Zheng J, Shibata DK. Microsatellite instability in sporadic endometrial carcinoma. J Natl Cancer Inst 1994;86:1216-21.
7. Helland A, Borresen-Dale AL, Peltomäki P, Hektoen M, Kristensen GB, Nesland JM, et al. Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 1997;70:499-501.
8. Gurin CC, Federici MG, Kang L, Boyd J. Causes and consequences of microsatellite instability in endometrial carcinoma. Cancer Res 1999;59:462-6.
9. Catasus L, Machin P, Matias-Guiu X, Prat J. Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases. Hum Pathol 1998;29:1160-4.
10. Esteller M, Levine R, Baylin SB, Ellenson LH, Herman JG. MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas. Oncogene 1998;17:2413-7.
11. Marcus VA, Madlensky L, Gryfe R, Kim H, So K, Millar A, et al. Immunohistochemistry for hMLH1 and hMSH2: a practical test for DNA mismatch repair-deficient tumors. Am J Surg Pathol 1999;23:1248-55.
12. Lindor NM, Burgart LJ, Leontovich O, Goldberg RM, Cunningham JM, Sargent DJ, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-8.
13. Leach FS, Polyak K, Burrell M, Johnson KA, Hill D, Dunlop MG, et al. Expression of the human mismatch repair gene hMSH2 in normal and neoplastic tissues. Cancer Res 1996, 56:235-40.
14. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-40.
15. Staebler A, Lax SF, Ellenson LH. Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability. Hum Pathol 2000;31:354-8.
16. Peiró G, Diebold J, Lohse P, Ruebsamen H, Lohse P, Baretton GB, et al. Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. Hum Pathol 2002;33:347-54.
17. Stone JG, Robertson D, Houlston RS. Immunohistochemistry for MSH2 and MLH1: a method for identifying mismatch repair deficient colorectal cancer. J Clin Pathol 2001;54:484-7.
18. de la Chapelle A. Microsatellite instability phenotype of tumors: genotyping or immunohistochemistry? The jury is still out [editorial]. J Clin Oncol 2002;20:897-9.
19. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med 1998;7:844-7.
20. Battifora H. The multitumor (sausage) tissue block: novel method for immunohistochemical antibody testing. Lab Invest 1986;55:244-8.
21. Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, et al. Tissue microarrays for gene amplification surveys in many diffrerent tumor types. Clin Cancer Res 1999;5:1966-75.
22. Kallioniemi OP, Wagner U, Kononen J, Sauter G. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet 2001;10:657-62.
23. Camp RL, Charette LA, Rimm DL. Validation of tissue microarray technology in breast carcinoma. Lab Invest 2000;80:1943-9.
24. Hoos A, Cordon-Cardo C. Tissue microarray profiling of cancer specimens and cell lines: opportunities and limitations. Lab Invest 2001;81:1331-8.
25. Moreno-Bueno G, Hardisson D, Sánchez C, Sarrio D, Cassia R, Garcia-Rostan G, et al. Abnormalities of the APC/β-catenin pathway in endometrial cancer. Oncogene 2002;21:7981-90.
26. Moreno-Bueno G, Gamallo C, Perez-Gallego L, Contreras F, Palacios J. β-Catenin expression pattern, β-catenin gene mutations, and microsatellite instability in endometriold ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 2001;10:116-22.
27. Palacios J, Catasus L, Moreno-Bueno G, Matias-Guiu X, Prat J, Gamallo C. β- and γ-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability. Virchows Arch 2001;438:464-9.
28. Gras E, Catasus L, Argüelles R, Moreno-Bueno G, Palacios J, Gamallo C, et al. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsateliites in ovarian tumors. Cancer 2001;92:2829-36.
29. Boland CR, Thibodeau SN, Hamilton SR, Sidranski D, Eshleman JR, Burt RW, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;58:5248-57.
30. Perucho M. Correspondence re: Boland CR et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the detection of microsatellite instability in colorectal cancer [letter]. Cancer Res 1999;59:249-56.
31. Zhou XP, Hoang JM, Li YI, Seruca R, Carneiro F, Sobrinho-Simoes M, et al. Determination of the replication error phenotype in human tumors without the requirement for matching normal DNA by analysis of mononucleotide repeat microsatellites. Genes Chromosomes Cancer 1998;21:101-7.
32. The International Federation of Obstetrics and Gynecology: 1988 revision. Gynecol Oncol 1989;35:125-7.
33. McDonald ND, Salvensen HB, Ryan A, Iversen OE, Akslen LA, Jacobs IJ. Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas. Cancer Res 2000;60:1750-2.
34. Basil JB, Goodfellow PJ, Rader JS, Mutch D, Herzog TJ. Clinical significance of microsatellite instability in endometrial carcinoma. Cancer 2000;89:1758-64.
35. Parc YR, Halling KC, Burgart LJ, McDonnell SK, Schaid DJ, Thibodeau SN, et al. Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: association with family history and histopathology. Int J Cancer 2000;86:60-6.
36. Moch H, Kononen J, Kallioniemi OP, Sauter G. Tissue microarrays: what will they bring to molecular and anatomic pathology? Adv Anat Pathol 2001;8:14-20.
37. Sallinen SL, Sallinen PK, Haapasalo HK, Helin HJ, Helen PT, Schraml P, et al. Identification of differently expressed genes in human gliomas by DNA microarray and tissue chip techniques. Cancer Res 2000;60:6617-22.
38. Mucci NR, Akdas G, Manely S, Rubin MA. Neuroendocrine markers in metastatic prostate cancer: evaluation of high throughput tissue microarraysto detect heterogeneous protein expression. Hum Pathol 2000;31:406-14.
39. Richter J, Wagner U, Kononen J, Fijan A, Bruderer J, Schmid U, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000;157:787-94.
40. Berends MJ, Hollema H, Wu Y, van Der Sluis T, Mensink RG, ten Hoor KA, et al. MLH1 and MSH2 protein expression as a pre-screening marker in hereditary and non-hereditary endometrial hyperplasia and cancer. Int J Cancer 2001;92:398-403.
41. Stefansson I, Akslen LA, MacDonald N, Ryan A, Das S, Jacobs IJ, et al. Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study. Clin Cancer Res 2002;8:138-43.
42. Katabuchi H, van Rees B, Lambers AR, Ronnett BM, Blazes MS, Leach FS, et al. Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 1995;55:5556-60.
43. Hendriks Y, Franken P, Dierssen JW, de Leeuw W, Wijnen J, Dreef E, et al. Conventional and tissue microarray immunohistochemical expression analysis of mismatch repair in hereditary colorectal tumors. Am J Pathol 2003;162:469-77.
44. Risinger JI, Umar A, Boyd J, Berchuck A, Kunkel TA, Barrett JC. Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nat Genet 1996;14:102-5.
45. Swisher EM, Mutch DG, Herzog TJ, Rader JS, Kowalski LD, Elbendary A, et al. Analysis of MSH3 in endometrial cancers with defective DNA mismatch repair. J Soc Gynecol Invest 1998;5:210-6.
46. Basil JB, Swisher EM, Herzog TJ, Rader JS, Elbendary A, Mutch DG, et al. Mutational analysis of the PMS2 gene in sporadic endometrial cancers with microsatellite instability. Gynecol Oncol 1999;74:395-9.
47. de Leeuw WJ, Dierssen J, Vasen HF, Wijnen JT, Kenter CG, Meijers-Heijboer H, et al. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumors from HNPCC patients. J Pathol 2000;192:328-35.
48. Müller W, Burgart LJ, Krause-Paulus R, Thibodeau SN, Almeida M, Brocker Edmonston T, et al. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC). Results of an international collaborative study. Familial Cancer 2001;1:87-93.
49. Manavis J, Gilham P, Davies R, Ruszkiewicz A. The immunohistochemical detection of mismatch repair gene proteins (MLH1, MSH2, MSH6, and PMS2): practical aspects in antigen retrieval and biotin blocking protocols. Appl Immunohistochem Mol Morphol 2003;11:73-7.
50. Ruszkiewicz A, Bennett G, Moore J, Manavis J, Rudzki B, Shen L, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathology 2002;34:541-7.